Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle-controlled, multicenter clinical trial
- Masutaka Furue
- , Yasumi Kitahara
- , Hideto Akama
- , Seiichiro Hojo
- , Nobukazu Hayashi
- , Hidemi Nakagawa
Research output: Contribution to journal › Article › peer-review
79
Link opens in a new tab
Citations
(Scopus)